Health
Australian-led international study: Full-dose blood thinners benefit moderately ill COVID-19 patients – Monash University
Full-dose anticoagulation with the blood thinner heparin improves survival outcomes and reduces the need for vital organ support…
05 August 2021
Full-dose anticoagulation with the blood thinner heparin improves survival outcomes and reduces the need for vital organ support such as mechanical ventilation in moderately ill COVID-19 patients, but does not yield the same positive outcomes…
Continue Reading
-
Noosa News14 hours agoQueensland coroner investigates ‘extremely unusual’ deaths of premature twin boys
-
General17 hours agoReuven Morrison was killed in the Bondi Beach shooting one year after warning about antisemitism
-
General17 hours agoNT’s top year 12 achievers celebrated, with some looking to pursue teaching careers
-
General14 hours agoSearch underway for missing boat off South Australia’s Cape Jaffa